Área exclusiva para Membros
Three years ago, we founded the Brazilian Association for the Study of Infiltration Treatment – ABETI, an evolution of the most important national event, ISIAT BRASIL (IB), aimed at discussing protocols and treatments by infiltration, which was already taking place in Europe, under the ISIAT name. As an emerging medical society, it was up to me to follow its first steps. In life we are constantly evolving and it couldn't be different with ABETI. So, let me tell you our story. Two editions of the IB took place, both in the city of Rio de Janeiro, in the years 2014 and 2016. In 2017, ABETI is created and presented internationally, in the same year, at ISIAT PRAGA. In 2018, we held the first genuinely national event on treatment by infiltration, the BRASIT – Brazilian Symposium on Injections Treatments. Our task was still arduous, but extremely captivating and passionate. We set goals in the short, medium and long term and, since then, we have tried to achieve them and it is gratifying to say that we are achieving success. In 2019, we held the COBRAVI – Brazilian Consensus on Viscosupplementation, and the knee joint was chosen. This document quickly became a national reference among doctors and a source of consultation for healthcare operators. We have conducted courses seeking to improve skeletal muscle infiltration techniques; managements with the main molecules used in the treatment by injection or infiltration, and the use of ultrasound as an aid tool for infiltration techniques. We established a communication channel, with public agencies and health operators, discussing health policies. ABETI grew exponentially and expanding our area ofoperation was a natural step. Thus, we understand that we should discuss at our events, not only the treatment by infiltration, but also the other therapeutic options in the treatment of musculoskeletal diseases. In 2019, we held the BRASOS TBT - Brazilian Symposium on Osteoarthritis, Osteoporosis and Sarcopenia - Target Based Treatment, a symposium to demonstrate a better understanding and management of Osteoarthritis and Sarcopenia showing a treatment proposal based on targets. We noticed our evolution and saw there, our identity, finally revealed and the name BRASOS – Brazilian Society for Osteoarthritis, Osteoporosis and Sarcopenia, was democratically chosen by our board. We are proactive and have gradually represented our young society in different national events and also our country, in different international events. We seek to encourage research and national scientific production and develop important projects, among which we mention: INFILTRA BRASIL, with educational and epidemiological objectives; the continuation of COBRAVI focusing on other articulations; a systematic review called Incorporation of Viscosupplementation in the ANS Procedures roll; BRAGOT – Brazilian Guidelines for Osteoarthritis Treatment is under development, with completion scheduled for December 2020.
Here is my thanks, to the encouraging friends for the creation of ABETI / BRASOS and to my dear members of the board, always active and competent. Nobody does anything alone and we do it all!
Congratulations to all of you!
Paulo Cesar Hamdan
President ABETI – BRASOS 2017-2020.